These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 15705891)
1. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Di C; Liao S; Adamson DC; Parrett TJ; Broderick DK; Shi Q; Lengauer C; Cummins JM; Velculescu VE; Fults DW; McLendon RE; Bigner DD; Yan H Cancer Res; 2005 Feb; 65(3):919-24. PubMed ID: 15705891 [TBL] [Abstract][Full Text] [Related]
2. Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Boon K; Eberhart CG; Riggins GJ Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863 [TBL] [Abstract][Full Text] [Related]
3. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208 [TBL] [Abstract][Full Text] [Related]
4. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways. Li J; Di C; Jing J; Di Q; Nakhla J; Adamson DC Int J Oncol; 2015 Nov; 47(5):1703-10. PubMed ID: 26397460 [TBL] [Abstract][Full Text] [Related]
6. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines. Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732 [TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization. Yokota N; Mainprize TG; Taylor MD; Kohata T; Loreto M; Ueda S; Dura W; Grajkowska W; Kuo JS; Rutka JT Oncogene; 2004 Apr; 23(19):3444-53. PubMed ID: 15064731 [TBL] [Abstract][Full Text] [Related]
8. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells. Bunt J; Hasselt NE; Zwijnenburg DA; Hamdi M; Koster J; Versteeg R; Kool M Int J Cancer; 2012 Jul; 131(2):E21-32. PubMed ID: 21964830 [TBL] [Abstract][Full Text] [Related]
9. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398 [TBL] [Abstract][Full Text] [Related]
10. Otx2 homeobox gene induces photoreceptor-specific phenotypes in cells derived from adult iris and ciliary tissue. Akagi T; Mandai M; Ooto S; Hirami Y; Osakada F; Kageyama R; Yoshimura N; Takahashi M Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4570-5. PubMed ID: 15557469 [TBL] [Abstract][Full Text] [Related]
11. All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells. Liu J; Guo L; Luo Y; Li JW; Li H Anticancer Res; 2000; 20(4):2659-64. PubMed ID: 10953340 [TBL] [Abstract][Full Text] [Related]
12. OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells. Bai RY; Staedtke V; Lidov HG; Eberhart CG; Riggins GJ Cancer Res; 2012 Nov; 72(22):5988-6001. PubMed ID: 22986744 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Otx2 expression and its functions in mouse forebrain and midbrain. Kurokawa D; Kiyonari H; Nakayama R; Kimura-Yoshida C; Matsuo I; Aizawa S Development; 2004 Jul; 131(14):3319-31. PubMed ID: 15201224 [TBL] [Abstract][Full Text] [Related]
14. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648 [TBL] [Abstract][Full Text] [Related]
15. Ontogenetic expression of the Otx2 and Crx homeobox genes in the retina of the rat. Rath MF; Morin F; Shi Q; Klein DC; Møller M Exp Eye Res; 2007 Jul; 85(1):65-73. PubMed ID: 17467693 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas. Bai R; Siu IM; Tyler BM; Staedtke V; Gallia GL; Riggins GJ Neuro Oncol; 2010 Jul; 12(7):655-63. PubMed ID: 20511190 [TBL] [Abstract][Full Text] [Related]
17. Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. Laboratory investigation. Kasuga C; Nakahara Y; Ueda S; Hawkins C; Taylor MD; Smith CA; Rutka JT J Neurosurg Pediatr; 2008 Apr; 1(4):305-13. PubMed ID: 18377306 [TBL] [Abstract][Full Text] [Related]
18. Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma. Wortham M; Guo C; Zhang M; Song L; Lee BK; Iyer VR; Furey TS; Crawford GE; Yan H; He Y PLoS One; 2014; 9(9):e107156. PubMed ID: 25198066 [TBL] [Abstract][Full Text] [Related]
19. Otx2 is required to respond to signals from anterior neural ridge for forebrain specification. Tian E; Kimura C; Takeda N; Aizawa S; Matsuo I Dev Biol; 2002 Feb; 242(2):204-23. PubMed ID: 11820816 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma. Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]